Skip to content

Developing and Assessing a Male Engagement Intervention in Option B+ in Malawi

Developing and Assessing a Male Engagement Intervention in Option B+ in Malawi: A Randomized Controlled Trial in Lilongwe

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03477279
Enrollment
1116
Registered
2018-03-26
Start date
2017-09-25
Completion date
2020-09-30
Last updated
2021-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hiv

Keywords

couple HIV testing and counseling, disclosure, Malawi

Brief summary

There is promising evidence that couple-based approaches within Malawi's Option B+ prevention of mother to child transmission program could address help address 1) poor male engagement in the HIV continuum of care, 2) low male adoption of biomedical HIV prevention approaches, 3) sub-optimal female engagement in the continuum of care, and 4) poor or uncertain infant outcomes. Our team has developed an intervention to address these challenges, and will conduct a randomized controlled trial (N=500 couples) to assess intervention effectiveness at one year. Women with recent HIV infections enrolled in this trial will be compared against a cohort of 350 HIV-uninfected women to explore predictors of HIV acquisition in pregnancy in Malawi.

Detailed description

In sub-Saharan Africa, engaging HIV-infected men in HIV care and treatment and engaging HIV-uninfected men in prevention has proven challenging. Along all steps of the HIV care-seeking cascade, men exhibit worse care-seeking behaviors. They are less likely to seek HIV testing and counseling (HTC), initiate combination antiretroviral therapy (cART), and be retained in cART care. Poor care-seeking has resulted in a lower prevalence of viral suppression and earlier mortality. Additionally, men rarely engage in the antenatal care-seeking of their female sexual partners, leading to worse maternal and infant outcomes. This low level of engagement has been noted in Malawi's Option B+ prevention of mother to child transmission (PMTCT) program, and has been a critical barrier to female Option B+ uptake and retention, and a missed opportunity for engaging men. There is promising evidence that couple-based approaches within Malawi's Option B+ prevention of mother to child transmission program could address all of these challenges: poor male engagement in the HIV continuum of care, low male adoption of biomedical HIV prevention approaches, sub-optimal female engagement in the continuum of care, and poor or uncertain infant outcomes. Our team has designed a couples-based intervention to address these challenges, and will conduct a randomized controlled trial (N=500 couples) to assess intervention effectiveness at one year. Results from this study are expected to inform how best to address family outcomes in an Option B+ program. This study has the following aims described below: Aim 1: Determine whether the couple-based intervention increases new HIV-positive diagnoses among HIV-infected male sex partners, helps HIV-infected men engage and remain in care, and contributes to male viral suppression compared to individual standard of care. The investigators will compare the couple-based intervention to standard of care for increasing the proportion of men who are aware of being HIV-infected, the proportion of these men who initiate and remain in cART care, and the proportion of these men with viral suppression at one year. Aim 2: Determine whether the couple-based intervention identifies HIV-discordant couples and decreases the likelihood of male exposure to HIV compared to individual standard of care. The investigators will compare the intervention to standard of care for increasing the number of men with non-HIV exposure from their female partner through consistent condom use, viral suppression, abstinence, or a combination of these methods over one year. Aim 3: Determine whether the couple-based intervention improves female cART retention and viral suppression compared to individual standard of care. The investigators will compare the intervention to standard of care for female cART retention and viral suppression at one year. Aim 4: Determine whether the couple-based intervention improves infant early infant diagnosis uptake compared to individual standard of care. Explore uptake of early infant diagnosis and rates of mother-to-child transmission and child survival in the two intervention arms. Aim 5: Develop an in-depth understanding of HIV transmission dynamics in Lilongwe. Using the biomarkers and behavioral survey, we will seek to understand transmission timing, direction, and context in Lilongwe. We will compare women with recent HIV infection to a population of HIV-uninfected controls (n=350) to understand predictors of HIV acquisition in pregnancy in Malawi.

Interventions

BEHAVIORALEnhanced Couple HIV Testing and Counseling

Participants are provided study-specific partner referral cards and encouraged to bring male partners to antenatal care for a male engagement intervention. Those who do not present on their own are then traced. Couples will receive three enhanced couple counseling sessions that include: pre-test counseling, return of joint results, and post-test counseling. HIV-infected men will be able to initiate cART at the antenatal clinic and the couple will be offered condoms from the HTC counselor. Between sessions, couple members can pick up condoms and cART for one another.

Sponsors

National Institute of Mental Health (NIMH)
CollaboratorNIH
University of North Carolina, Chapel Hill
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
15 Years to No maximum
Healthy volunteers
No

Inclusion criteria

(HIV-infected Women): * HIV-infected and eligible for Option B+ * \>18 years old or 15-17 years old and married * Planning to remain in the Bwaila catchment area for the next year or notify the study team if they leave the area or change facilities * Part of a heterosexual relationship for \>3 months * Expects the partner to be in the relevant catchment area for at least one week in the next six months. * Able and willing to give locator information for this partner * Willing to have study staff conduct phone and physical tracing of that partner * Willing to undergo a couple-based intervention with this partner * Able and willing to provide informed consent Inclusion Criteria (Male Partners of HIV-infected women) * \>18 years old or 15-17 years old and married * In a relationship with the female partner for \>3 months * Willing to undergo a couples-based intervention with their female partner * Able and willing to provide informed consent Inclusion Criteria (HIV-uninfected Women): * HIV-uninfected * \>18 years old or 15-17 years old and married * Part of a heterosexual relationship for \>3 months * Expects the partner to be in the relevant catchment area for at least one week in the next six months. * Willing to receive couples-based HIV testing and counseling with this partner * Able and willing to provide informed consent

Exclusion criteria

(all Women and Male Partners): • Any condition that in the opinion of the study investigator would compromise the ability of the prospective participant to provide informed consent, undergo study procedures safely, or would prevent proper conduct of the study.

Design outcomes

Primary

MeasureTime frameDescription
Number of HIV-negative Men Without HIV Exposure From Their Primary Partner12 monthsHIV-negative men with a) consistent condom use in the last six months or b) a suppressed female partner or c) abstinence with primary partner
Number of HIV-positive Male Partners Retained in Care12 monthsHIV-positive male partners who presented at 12 months and reported taking at least one dose of ART in the last seven days
Number of HIV-positive Male Partners With Viral Suppression12 monthsHIV-positive male partners who presented at 12 months with a viral load \<1000 copies/mL
Number of Women Retained in Care12 monthsWomen who presented at 12 months and reported taking at least one dose of ART in the last seven days
Number of Women With Viral Suppression12 monthsWomen who presented at 12 months with a viral load \<1000 copies/mL
Number of HIV-positive Male Partners Aware of Their HIV-positive Status12 monthsHIV-positive male partners who presented at 12 months and reported knowing they were HIV-positive prior to receiving the results of the HIV test conducted at the 12 month study visit

Secondary

MeasureTime frameDescription
Predictors of Recent HIV InfectionAt the day of female consentRisk factor analysis to identify predictors of recent HIV infection among pregnant women
Number of HIV-positive Female Participants Who Reported Early Infant Diagnosis12 monthsHIV-positive female participants who reported a live birth and uptake of early infant diagnosis

Countries

Malawi

Participant flow

Participants by arm

ArmCount
Individual (HIV+ Women)
HIV-positive pregnant women enrolled in the Individual arm will receive Standard of Care Option B+ procedures.
246
Couple (HIV+ Women)
HIV-positive pregnant women enrolled in the Couple arm will receive 1) support to recruit their male partners, 2) enhanced couple counseling and testing, and 3) support for male partner engagement in care.
249
Male Partners of Women in Individual
These men will have access to standard of care procedures.
98
Male Partners of Women in Couple
These men will receive 1) support with recruitment, 2) enhanced couple counseling and testing, and 3) support for engagement in care.
167
Control Population (HIV- Women)
HIV-negative pregnant women will be invited to participate in a cross-sectional study. No intervention will be provided and no follow-up will be conducted.
349
Total1,109

Baseline characteristics

CharacteristicTotalCouple (HIV+ Women)Male Partners of Women in IndividualMale Partners of Women in CoupleIndividual (HIV+ Women)Control Population (HIV- Women)
Age, Categorical
<=18 years
64 Participants11 Participants1 Participants0 Participants15 Participants37 Participants
Age, Categorical
>=65 years
0 Participants0 Participants0 Participants0 Participants0 Participants0 Participants
Age, Categorical
Between 18 and 65 years
1045 Participants238 Participants97 Participants167 Participants231 Participants312 Participants
Race and Ethnicity Not Collected0 Participants
Region of Enrollment
Malawi
1109 Participants249 Participants98 Participants167 Participants246 Participants349 Participants
Sex: Female, Male
Female
844 Participants249 Participants0 Participants0 Participants246 Participants349 Participants
Sex: Female, Male
Male
265 Participants0 Participants98 Participants167 Participants0 Participants0 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
EG003
affected / at risk
EG004
affected / at risk
deaths
Total, all-cause mortality
1 / 2501 / 2500 / 980 / 1680 / 0
other
Total, other adverse events
0 / 2500 / 2500 / 980 / 1680 / 0
serious
Total, serious adverse events
0 / 2500 / 2500 / 980 / 1680 / 0

Outcome results

Primary

Number of HIV-negative Men Without HIV Exposure From Their Primary Partner

HIV-negative men with a) consistent condom use in the last six months or b) a suppressed female partner or c) abstinence with primary partner

Time frame: 12 months

Population: This is a male only outcome. 162 did not present at 12 months, or refused HIV testing at 12 months, or tested HIV-positive/indeterminate at 12 months

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Individual (HIV+ Women)Number of HIV-negative Men Without HIV Exposure From Their Primary Partner39 Participants
Couple (HIV+ Women)Number of HIV-negative Men Without HIV Exposure From Their Primary Partner59 Participants
95% CI: [-13.2, 8.5]
Primary

Number of HIV-positive Male Partners Aware of Their HIV-positive Status

HIV-positive male partners who presented at 12 months and reported knowing they were HIV-positive prior to receiving the results of the HIV test conducted at the 12 month study visit

Time frame: 12 months

Population: This is a male only outcome. 141 men did not present at 12 months, or refused HIV testing at 12 months, or tested HIV-negative/indeterminate at 12 months

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Individual (HIV+ Women)Number of HIV-positive Male Partners Aware of Their HIV-positive Status44 Participants
Couple (HIV+ Women)Number of HIV-positive Male Partners Aware of Their HIV-positive Status67 Participants
95% CI: [-1.7, 21.7]
Primary

Number of HIV-positive Male Partners Retained in Care

HIV-positive male partners who presented at 12 months and reported taking at least one dose of ART in the last seven days

Time frame: 12 months

Population: This is a male only outcome. 142 men did not present at 12 months, or refused HIV testing at 12 months, or tested HIV-negative/indeterminate at 12 months, or did not report information on ART use

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Individual (HIV+ Women)Number of HIV-positive Male Partners Retained in Care34 Participants
Couple (HIV+ Women)Number of HIV-positive Male Partners Retained in Care59 Participants
95% CI: [0.9, 32.3]
Primary

Number of HIV-positive Male Partners With Viral Suppression

HIV-positive male partners who presented at 12 months with a viral load \<1000 copies/mL

Time frame: 12 months

Population: This is a male only outcome. 141 men did not present at 12 months, or refused HIV testing at 12 months, or tested HIV-negative/indeterminate at 12 months, or did not provide the blood sample required for viral load ascertainment

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Individual (HIV+ Women)Number of HIV-positive Male Partners With Viral Suppression31 Participants
Couple (HIV+ Women)Number of HIV-positive Male Partners With Viral Suppression53 Participants
95% CI: [-1.6, 31.8]
Primary

Number of Women Retained in Care

Women who presented at 12 months and reported taking at least one dose of ART in the last seven days

Time frame: 12 months

Population: This is an HIV-positive female only outcome. 134 HIV-positive women did not present for the 12 month study visit

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Individual (HIV+ Women)Number of Women Retained in Care160 Participants
Couple (HIV+ Women)Number of Women Retained in Care164 Participants
95% CI: [-5.6, 7.3]
Primary

Number of Women With Viral Suppression

Women who presented at 12 months with a viral load \<1000 copies/mL

Time frame: 12 months

Population: This is an HIV-positive female only outcome.138 HIV-positive women did not present for the 12 month study visit or did not provide the blood sample required for viral load ascertainment

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Individual (HIV+ Women)Number of Women With Viral Suppression145 Participants
Couple (HIV+ Women)Number of Women With Viral Suppression162 Participants
95% CI: [-0.8, 14]
Secondary

Number of HIV-positive Female Participants Who Reported Early Infant Diagnosis

HIV-positive female participants who reported a live birth and uptake of early infant diagnosis

Time frame: 12 months

Population: This is an HIV-positive female only outcome. For 154 observations, there was no data available on infant outcomes or no live birth

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Individual (HIV+ Women)Number of HIV-positive Female Participants Who Reported Early Infant Diagnosis162 Participants
Couple (HIV+ Women)Number of HIV-positive Female Participants Who Reported Early Infant Diagnosis158 Participants
95% CI: [-10, 10.7]
Secondary

Predictors of Recent HIV Infection

Risk factor analysis to identify predictors of recent HIV infection among pregnant women

Time frame: At the day of female consent

Population: This is a female only outcome. Of the 500 HIV-positive women enrolled into the study, 44 were classified as having recently acquired HIV. Data unavailable for one HIV-negative woman.

ArmMeasureCategoryValue (COUNT_OF_PARTICIPANTS)
Individual (HIV+ Women)Predictors of Recent HIV InfectionMarried to Primary Partner38 Participants
Individual (HIV+ Women)Predictors of Recent HIV InfectionNot Married to Primary Partner6 Participants
Couple (HIV+ Women)Predictors of Recent HIV InfectionMarried to Primary Partner338 Participants
Couple (HIV+ Women)Predictors of Recent HIV InfectionNot Married to Primary Partner11 Participants
95% CI: [1.7, 13.9]

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026